A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with a substantial market capitalization of $110.13 billion, continues to ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

£500K grant for the development of precision antibiotics targeting AMR lung infections in people with cystic fibrosis.